CG:603658 Autobio Diagnostics Co., Ltd

Autobio Diagnostics Co., Ltd. engages in the research and development, production, and distribution of clinical diagnostic products in China and internationally. It develops immunoassay, biochemistry, microbiology, and IVD reagents; and instruments, such as automation and semi-automation systems, as well as medical laboratory solutions. The company's immunoassay products AutoLumo A2000 Plus, an automatic Chemiluminescence immunoassay analyzer; automatic microplate chemiluminescent enzyme immunoassay; and LUmo luminometers, PHOmo microplate readers, and iWO microplate washers. Its microbiology products comprise automated mass spectrometry microbial identification systems, automated blood culture systems; and blood culture bottles, AUTOMIC strips, and mycoplasma IES. The company was formerly known as Lifeclone Diagnostics Co., Ltd. and changed its name to Autobio Diagnostics Co., Ltd. in 2003. Autobio Diagnostics Co., Ltd. was founded in 1998 and is based in Zhengzhou, China. Autobio Diagnostics Co., Ltd. is a subsidiary of Zhengzhou Auto Industrial Co., Ltd.

48.00 CNY
As of 01/27/2022

Security Information
Category1:  Global Equity
Category2:  Common stocks
Category3:  Emerging markets
GICS sector:  Health Care
Industry:  Diagnostics & Research
Index country:  China
Country of incorporation:  China
IPO date:  01/02/2018
Stock exchange:    Shanghai Stock Exchange
Exchange country:   China
Market cap:   28,141,056,000 CNY
Current dividend yield:   1.26%
Sedol:      BYW5N89

2022 © Stock Market MBA, Inc. Terms of use | Privacy policy